Showing 1 - 20 results of 83 for search '"ГИСТОЛОГИЧЕСКОЕ СТРОЕНИЕ"', query time: 0.83s Refine Results
  1. 1
    Academic Journal

    Source: Вестник Бурятской государственной сельскохозяйственной академии имени В. Р. Филиппова. :77-84

  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
    Academic Journal

    Source: Cancer Urology; Том 18, № 1 (2022); 112-120 ; Онкоурология; Том 18, № 1 (2022); 112-120 ; 1996-1812 ; 1726-9776

    File Description: application/pdf

    Relation: https://oncourology.abvpress.ru/oncur/article/view/1488/1346; Steyerberg E.W., Keizer H.J., Fossa S.D. et al. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol 1995;13(5):1177–87. DOI:10.1200/JCO.1995.13.5.1177.; Eggener S.E., Carver B.S., Loeb S. et al. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors. Cancer 2007;109(3):528–35. DOI:10.1002/cncr.22440.; Wood D.P.Jr, Herr H.W., Motzer R.J. et al. Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers. Cancer 1992;70(9):2354–7. DOI:10.1002/1097-0142(19921101)70:93.0.co;2-u.; Murphy B.R., Breeden E.S., Donohue J.P. et al. Surgical salvage of chemorefractory germ cell tumors. J Clin Oncol 1993;11(2):324–9. DOI:10.1200/JCO.1993.11.2.324.; Eastham J.A., Wilson T.G., Russell C. et al. Surgical resection in patients withnonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy. Urology 1994;43(1):74–80. DOI:10.1016/s0090-4295(94)80269-6.; CooganC.L., Foster R.S., Rowland R.G. et al. Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone. Urology 1997;50(6):957–62. DOI:10.1016/S0090-4295(97)00458-5.; Ravi R., Ong J., Oliver R.T. et al. Surgery as salvage therapy in chemotherapy-resistant nonseminomatous germ cell tumours. Br J Urol 1998;81(6):884–8. DOI:10.1046/j.1464-410x.1998.00346.x.; Albers P., Ganz A., Hannig E. et al. Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers. J Urol 2000;164(2):381–4.; Habuchi T., Kamoto T., Hara I. et al. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers. Cancer 2003;98(8):1635–42. DOI:10.1002/cncr.11711.; Beck S.D., Foster R.S., Bihrle R. et al. Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol 2005;23(25):6149–56. DOI:10.1200/JCO.2005.11.684.; Ong T.A., Winkler M.H., Savage P.M. et al. Retroperitoneal lymph node dissection after chemotherapy in patients with elevated tumour markers: indications, histopathology and outcome. BJU Int 2008;102(2):198–202. DOI:10.1111/j.1464-410X.2008.07533.x.; Steiner H., Berg B., Stöhr B. et al. Prediction of retroperitoneal histology in metastatic nonseminomatous testicular cancer patients after chemotherapy based on clinical and radiological parameters. Curr Urol 2010;4:142–51. DOI:10.1159/000253441; Dieckmann K.P., Simonsen-Richter H., Kulejewski M. et al. Serum tumour markers in testicular germ cell tumours: frequencies of elevated levels and extents of marker elevation are significantly associated with clinical parameters and with response to treatment. Biomed Res Int 2019;2019:5030349. DOI:10.1155/2019/5030349.; Трякин А.А., Федянин М.Ю., Буланов А.А. и др. Лечение больных несеминомными герминогенными опухолями неблагоприятной прогностической группы с большой распространенностью опухолевого процесса. Злокачественные опухоли 2017;(3):23–9. DOI:10.18027/2224-5057-2017-3-23-29.; Van der Gaast A., Hoekstra J.W., Croles J.J. et al. Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic ifferentiated mature teratoma. J Urol 1991;145(4):829–31. DOI:10.1016/s0022-5347(17)38465-3.; Beck S.D., Patel M.I., Sheinfeld J. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors. J Urol 2004;171(1):168–71. DOI:10.1097/01.ju.0000099714.16082.78.; Hartmann J.T., Candelaria M., Kuczyk M.A. et al. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic nonseminomatous germ cell tumours. Eur J Cancer 1997;33(6):843–7. DOI:10.1016/s0959-8049(96)00517-5.; https://oncourology.abvpress.ru/oncur/article/view/1488

  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
    Academic Journal

    File Description: application/pdf

    Relation: Голубев, Д. С. Особенности гистологического строения расширенной и пограничной частей кишечника у среднего и крупного товарного карпа гибридной породы / Д. С. Голубев, Д. Ф. Карелин, С. Л. Радченко // Веснік Віцебскага дзяржаўнага ўніверсітэта. – 2023. – № 4. – С. 37–43.; 9a737fe014930fc133e54d23085ec3d8; https://rep.vsu.by/handle/123456789/40883

  20. 20
    Academic Journal

    File Description: application/pdf

    Relation: Голубев, Д. С. Сравнительное гистологическое строение расширенной и обычной частей кишечника у среднего и крупного товарного карпа гибридной породы / Д. С. Голубев // Веснік Віцебскага дзяржаўнага ўніверсітэта. – 2023. – № 4. – С. 17–23.; ecdfd2b20f83be273951872e28c1217e; https://rep.vsu.by/handle/123456789/40880